S

Sanbo Hospital Management Group Ltd
SZSE:301293

Watchlist Manager
Sanbo Hospital Management Group Ltd
SZSE:301293
Watchlist
Price: 64.12 CNY 0.38% Market Closed
Market Cap: ¥13.2B

Sanbo Hospital Management Group Ltd
Cash from Investing Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sanbo Hospital Management Group Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Cash from Investing Activities
-¥390m
CAGR 3-Years
-39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Cash from Investing Activities
-¥3.3B
CAGR 3-Years
0%
CAGR 5-Years
-16%
CAGR 10-Years
-17%
INKON Life Technology Co Ltd
SZSE:300143
Cash from Investing Activities
-¥672.6m
CAGR 3-Years
-18%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
I
Innovative Medical Management Co Ltd
SZSE:002173
Cash from Investing Activities
-¥1.3m
CAGR 3-Years
N/A
CAGR 5-Years
70%
CAGR 10-Years
19%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Cash from Investing Activities
-¥247.2m
CAGR 3-Years
N/A
CAGR 5-Years
31%
CAGR 10-Years
6%
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Cash from Investing Activities
-¥747.5m
CAGR 3-Years
-65%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
No Stocks Found

Sanbo Hospital Management Group Ltd
Glance View

Market Cap
13.2B CNY
Industry
Health Care

Sanbo Hospital Management Group Ltd., rooted in the bustling heart of China's healthcare sector, stands as a beacon of modern medical management and innovation. Founded with the mission to address the ever-growing healthcare demands of an expanding urban population, Sanbo has adeptly navigated the complexities of the industry through its impressive network of specialized hospitals and clinics. This enterprise thrives by streamlining hospital operations and fostering an environment where cutting-edge technologies meet compassionate care. By focusing primarily on neurology, a field with increasing incidence and demand globally, Sanbo captures a niche market. Its approach showcases a blend of expertise, employing skilled medical professionals coupled with state-of-the-art medical facilities, thereby enhancing the quality of patient outcomes and drawing a steady stream of clientele. The company's revenue engine hums efficiently by scaling its specialized services and implementing a multi-layered service model. Sanbo generates income through various channels, including direct patient care, diagnostic services, surgical treatments, and long-term patient management programs. Additionally, the firm harnesses strategic partnerships and collaborations with both public and private sectors to expand its reach and improve healthcare accessibility. A notable portion of its revenue also emanates from offering consultancy services to lesser-equipped hospitals looking to optimize their operations. By spearheading initiatives in research and development, Sanbo not only broadens its expertise but also attracts intellectual capital and investments. Each layer of its operations synergistically works to strengthen its foothold in the healthcare market, creating a sustainable model that continues to thrive amidst the evolving medical landscape.

Intrinsic Value
19.75 CNY
Overvaluation 69%
Intrinsic Value
Price ¥64.12
S

See Also

What is Sanbo Hospital Management Group Ltd's Cash from Investing Activities?
Cash from Investing Activities
-390m CNY

Based on the financial report for Dec 31, 2024, Sanbo Hospital Management Group Ltd's Cash from Investing Activities amounts to -390m CNY.

What is Sanbo Hospital Management Group Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-39%

Over the last year, the Cash from Investing Activities growth was 61%. The average annual Cash from Investing Activities growth rates for Sanbo Hospital Management Group Ltd have been -39% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett